Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H13N3O2 |
Molecular Weight | 231.2505 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(N1CCCCC1)C2=CC3=NON=C3C=C2
InChI
InChIKey=XFVRBYKKGGDPAJ-UHFFFAOYSA-N
InChI=1S/C12H13N3O2/c16-12(15-6-2-1-3-7-15)9-4-5-10-11(8-9)14-17-13-10/h4-5,8H,1-3,6-7H2
Molecular Formula | C12H13N3O2 |
Molecular Weight | 231.2505 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
CNS Activity
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Current management of the cognitive dysfunction in Parkinson's disease: how far have we come? | 2008 Aug |
|
Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat. | 2009 Jan |
|
Glutamatergic targets for enhancing extinction learning in drug addiction. | 2010 Dec |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:36:07 GMT 2023
by
admin
on
Fri Dec 15 16:36:07 GMT 2023
|
Record UNII |
7X6P5N8K2L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29710
Created by
admin on Fri Dec 15 16:36:07 GMT 2023 , Edited by admin on Fri Dec 15 16:36:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
FARAMPATOR
Created by
admin on Fri Dec 15 16:36:07 GMT 2023 , Edited by admin on Fri Dec 15 16:36:07 GMT 2023
|
PRIMARY | |||
|
DB15012
Created by
admin on Fri Dec 15 16:36:07 GMT 2023 , Edited by admin on Fri Dec 15 16:36:07 GMT 2023
|
PRIMARY | |||
|
211735-76-1
Created by
admin on Fri Dec 15 16:36:07 GMT 2023 , Edited by admin on Fri Dec 15 16:36:07 GMT 2023
|
PRIMARY | |||
|
CHEMBL1276138
Created by
admin on Fri Dec 15 16:36:07 GMT 2023 , Edited by admin on Fri Dec 15 16:36:07 GMT 2023
|
PRIMARY | |||
|
7X6P5N8K2L
Created by
admin on Fri Dec 15 16:36:07 GMT 2023 , Edited by admin on Fri Dec 15 16:36:07 GMT 2023
|
PRIMARY | |||
|
100000174953
Created by
admin on Fri Dec 15 16:36:07 GMT 2023 , Edited by admin on Fri Dec 15 16:36:07 GMT 2023
|
PRIMARY | |||
|
4118151
Created by
admin on Fri Dec 15 16:36:07 GMT 2023 , Edited by admin on Fri Dec 15 16:36:07 GMT 2023
|
PRIMARY | |||
|
8534
Created by
admin on Fri Dec 15 16:36:07 GMT 2023 , Edited by admin on Fri Dec 15 16:36:07 GMT 2023
|
PRIMARY | |||
|
DTXSID90175413
Created by
admin on Fri Dec 15 16:36:07 GMT 2023 , Edited by admin on Fri Dec 15 16:36:07 GMT 2023
|
PRIMARY | |||
|
C65620
Created by
admin on Fri Dec 15 16:36:07 GMT 2023 , Edited by admin on Fri Dec 15 16:36:07 GMT 2023
|
PRIMARY | |||
|
QQ-90
Created by
admin on Fri Dec 15 16:36:07 GMT 2023 , Edited by admin on Fri Dec 15 16:36:07 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->POSITIVE ALLOSTERIC MODULATOR (PAM) |
Low-impact AMPAR PAMs decrease AMPAR deactivation (channel closing) alone to augment synaptic currents
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|